Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update outlines long-term efficacy and safety investigations of fecal microbiota transplantation for ulcerative colitis, with Phase 2 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Ulcerative Colitis, Fecal Microbiota Transplantation | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION